The Affiliated Hospital Of Xuzhou Medical University
Clinical trials sponsored by The Affiliated Hospital Of Xuzhou Medical University, explained in plain language.
-
New combo therapy aims to control MS in early trial
Disease control Not yet recruitingThis early-phase study tests a combination of a CD20 antibody and NK042 cell injection in 20 adults with multiple sclerosis. The goal is to see if the treatment is safe and can help control the disease. Participants will be monitored for side effects and changes in disability ove…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 17, 2026 03:24 UTC
-
Heart attack drug trial aims to prevent future cardiac events
Disease control Not yet recruitingThis study tests whether the drug tafolecimab, given before a procedure to open blocked heart arteries, can reduce the risk of major heart problems like another heart attack or stroke over one year. About 1,160 adults aged 18-75 who are having a heart attack will receive either t…
Phase: PHASE4 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Could immune reset with donor CAR T-Cells tame lupus?
Disease control Not yet recruitingThis early-phase study tests a universal (donor-derived) CAR T-cell therapy called QT-019C in 15 adults with lupus or inflammatory myositis that has not responded to standard treatments. The therapy targets two immune-cell markers (CD19 and BCMA) to reset the faulty immune system…
Phase: EARLY_PHASE1 • Sponsor: The Affiliated Hospital of Xuzhou Medical University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC